摘要
金属蛋白酶组织抑制因子(TIMPs)是一组具有许多共同生理、生化性质的活性蛋白质,它们在体内水平的变化、分布的差异,均对机体生命的病理、生理过程产生重要的影响.现就TMIPs的研究现状及其与肝纤维化的关系综述如下.
出处
《临床消化病杂志》
2003年第1期37-39,共3页
Chinese Journal of Clinical Gastroenterology
参考文献28
-
1[1]Brew K. Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases; evolution, structure and tunction. Biochim Biophys Acta, 2000,1447(1～2):267.
-
2[2]De clerck YA, Yeah TD, Ratzkin BJ, et al. Purification and characterization of two related but distinct metalloptroteinase inhibitors by bovine aortic endothelial . J Biol Chem, 1989,264(29): 17445.
-
3[3]Osthues A, Knauper V, Oberhoff R, et al. Isolation and characterization of tissue inhibitor of metalloproteinases (TIMP-1 and TIMP-2) from human rheumaoid synovial fluid. FEBS, 1992;296(2) :231.
-
4[4]Iredale JP, Benyon RC, Arthur MJ. et al. Tissue inhibitor of metallo-proteinase-1 RNA in experimental liver injury and fibrosis hepatology. 1996,24(1):176.
-
5[5]Pavloff N,Staskus PW, Kishinani NS, et al. A new inhibitor of metallo proteinses from chicken: chTIMP-3. A third member of the TIMP family J Biol Chem, 1992,267(24) :17321.
-
6[6]Leco KJ, Khokha R, Pavloff N, et al. Tissue inhibitor of melalloproteinase-3(TIMP-3)is an ectracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues. J Biol,Chem, 1994,269(12):9352.
-
7[7]Greene J,Wang M, Liu YE, et al. Molecular cloning and characteriz ation of human tissue inhibitor of metalloproteinase. J Biol Chem, 1996, 27 (48):30375.
-
8[8]Wang M, Liu YE, Greene J, et al. Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metallo-proteinase-4. Oneogene, 1997,14(23) :2767.
-
9[9]Herbst H, Wege T, Milani S, et al . Tissue inhibitor of metalloproteinaes-1 and -2 RNA expression in rat and human liver fibrosis . Am J Pathol, 1997,150(5) :1647.
-
10[10]Benyon RC, lredale JP, Goddard S, et al. Expression of inhibitor of metalloproteinaese 1 and 2 is increased in fibrotic human liver. Gastroenterology.1996,110(3) :821.
同被引文献11
-
1Kobayashi H, U ZX, Yamataka A, et al. Clinical evaluation of serum levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases as predictors of progressive fibrosis in postoperative biliary atresia patients.J Pediatr Surg, 2002, 37(7) : 1030 - 1033.
-
2Knittel T, Mehde M, Gmndmann A, et al.Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat. Histochem Cell Biol, 2000, 113(6):443 - 53.
-
3Benyon RC, ArthurMJR. Mechanisms of hepaic fibrosis.J Pedimr Gastroenterol Nutr, 1998, 27:75 - 85.
-
4Friedman SL. The cellular basis of hepatic fibrosis: mechanisms and treatment strategies. N Engl J Med 1993, 323:1828 -1835.
-
5Thomas Knittel,Mirko Mehde,Anka Grundmann,Bernhard Saile,Jens-Gerd Scharf,Giuliano Ramadori. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat[J] 2000,Histochemistry and Cell Biology(6):443～453
-
6梁志清.细胞外基质的降解代谢与肝纤维化[J].国外医学（生理病理科学与临床分册）,1998,18(4):352-354. 被引量：9
-
7杨长青,胡国龄,谭德明,张铮.实验性肝纤维化时MMP-1、TIMP-1的表达与Ⅰ、Ⅲ型胶原含量变化的关系[J].临床肝胆病杂志,2000,16(4):222-224. 被引量：23
-
8辛绍杰,邹正升.细胞外基质的代谢[J].世界华人消化杂志,2002,10(1):54-56. 被引量：16
-
9周光德,赵景民.细胞外基质在肝内的代谢与肝纤维化的形成[J].世界华人消化杂志,2002,10(1):57-59. 被引量：17
-
10崔红燕.基质金属蛋白酶与肝纤维化的研究进展[J].国外医学（消化系疾病分册）,2003,23(1):37-40. 被引量：24
引证文献2
-
1谢汝佳,杨勤,耿晓霞,罗新华,李诚秀,程明亮.中药丹芍化纤胶囊对肝纤维化大鼠金属蛋白酶组织抑制因子-1表达的影响[J].中国中西医结合杂志,2005,25(S1):59-62. 被引量：1
-
2谢汝佳,杨勤,耿晓霞,罗新华,李诚秀,程明亮.丹芍化纤胶囊治疗大鼠肝纤维化对金属蛋白酶组织抑制因子-1表达的影响[J].贵阳中医学院学报,2005,27(1):54-57. 被引量：5
二级引证文献6
-
1胡义扬.中医药抗肝纤维化的研究[J].实用临床医药杂志,2005,9(7):18-22. 被引量：19
-
2洪朝金.肝纤维化病机治法研究概况[J].中华中医药学刊,2007,25(2):330-331. 被引量：3
-
3史保生,侯瑞芳,吴君,程明亮.丹芍化纤胶囊对肝纤维化大鼠PDGFR-β和p-ERK1/2的影响[J].世界华人消化杂志,2007,15(6):574-579. 被引量：2
-
4袁建,杨宇.基质金属蛋白酶-1、基质金属蛋白酶抑制剂-1与肝纤维化的中医治疗[J].井冈山大学学报（自然科学版）,2010,31(5):106-108. 被引量：9
-
5高湲,陈桂敏,梁振钰,谢毅强.细胞因子对肝纤维化影响的中医药研究进展[J].海南医学,2013,24(1):111-113. 被引量：8
-
6吴若云,鲁玉辉,徐文洋.从阴阳理论探讨肝纤维化的病机及治法[J].世界中医药,2015,10(11):1784-1788. 被引量：1
-
1贾海琴,杨国香.血清脂联素对心血管疾病的诊断价值[J].疾病监测与控制,2008,2(3):183-184.
-
2孔云,孔雷.城镇老年人心律失常病因探讨[J].中国实用心电杂志,1998,19(6):382-382.
-
3曾超.肺泡蛋白沉着症2例报道及文献复习[J].临床和实验医学杂志,2007,6(3):162-163. 被引量：1
-
4黄菲蕾.低分子量肝素的生化性质及其在国外的临床应用[J].中山大学研究生学刊（自然科学与医学版）,2000,21(3):50-57.
-
5翁军,张风林.肺泡蛋白沉积症5例临床分析[J].山东医药,2008,48(13):90-90.
-
6何展荣.生理性质与物理性质、化学性质的关系初探[J].川北教育学院学报,1997,7(4):59-61.
-
7邱晓昀,宋军民.高血压患者胰岛素抵抗、血清脂联素与动脉粥样硬化相关性分析[J].中国乡村医药,2012,19(16):47-48. 被引量：1
-
8王国凤,胡新贵,申晓彧.冠心病及冠心病合并糖尿病患者血糖与血浆P-选择素相关性研究[J].中西医结合心脑血管病杂志,2009,7(4):475-477. 被引量：7
-
9李建飞,李志红,李玉林.微量元素铬与糖尿病[J].微量元素与健康研究,2002,19(3):73-74. 被引量：21
-
10张修健,韩范锡,丁清明,吴玫涵.心活素的生化性质及其对心肌细胞DNA合成的影响[J].药物生物技术,1996,3(2):98-100. 被引量：1
